Navigation Links
Patheon-Sponsored Event to Highlight “Product Enhancement Through Complex Dosage Forms: Adding Value to Products’ Lifecycle Management”
Date:6/5/2013

(PRWEB) June 05, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, is hosting a complimentary, half-day seminar on “Product Enhancement through Complex Dosage Forms: Adding Value to Products’ Lifecycle Management” on June 18, 2013 at the MassBio Headquarters in Cambridge, Massachusetts.

Complex dosage forms provide novel business opportunities for companies to leverage their existing products and intellectual property. Pharmaceutical industry experts will discuss several life cycle management strategies to enhance the product life cycle and extend the life of a drug.

Topics covered, but not limited to, include:

  • How to enhance existing product portfolio
  • How to improve and register existing marketed products
  • How to get a product to the market, including regulatory filing and approval requirements for complex dosage forms
  • Challenges for a sterile solution that requires lyophilization in order to meet commercial stability requirements
  • Drug formulation considerations in order to get a lyophilized product commercialized

Presentations will be provided by Patheon employees, Anil Kane, Ph.D., MBA, Executive Director, Global PDS Formulation Sciences, and Don Barbieri, Associate Director of Formulation and Process Development, as well as by Doug Stockdale, MBA, Life Sciences Executive, and John McCarty, Consultant with Pharmaceutical Productions.    

Visit the company’s website at http://www.patheon.com/Knowledge-Library/Events.aspx to learn more or register for the upcoming seminar. Seating is limited.

About Patheon

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 17 locations, including 13 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10789471.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Louis Amendolagine and Dr. Geri Friefeld Launch a Ground Breaking Cavity Prevention Program That Lowers Decay Rates by 74%
2. Dr. Althauser Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
3. Health Diagnostic Laboratory, Inc.s new Diabetes Prevention & Management Panel incorporates discovery from Metabolon researchers
4. Brookfield Dental Care Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
5. Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches
6. Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It
7. Probiotic Action The “Best Acne Treatment” Shares New Insight on the Future of Preventing the Spread of Acne Causing Germs
8. A Media Event on Clinical Developments in Gene and Cell Therapy
9. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
10. Marshfield Dentist Launches Groundbreaking Cavity Prevention Program That Can Lower Tooth Decay Rates by 74 Percent
11. Dentistry at Somerset Launches Ground Breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... Village, CA (PRWEB) , ... August 17, 2017 ... ... technology for cancer research and personalized medicine, today announced the launch of a ... Kansas City, Missouri. The study’s goal is to evaluate the potential for early ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... different cell type. Many treatments for specific cancers, such as breast, prostate, or ... treatment is androgen deprivation therapy for advanced prostate cancer. , This therapy ...
(Date:8/16/2017)... ... August 16, 2017 , ... We are proud to announce ... at our Dilworth, MN site. The inspection took place Monday, July 31st through ... part of a routine Bioresearch Monitoring Program (BIMO) with the USFDA wherein multiple ...
(Date:8/15/2017)... STANFORD, Calif. , Aug. 15, 2017 After spending ... resources and support with crowdsourced data collection, GeneFo now offers this ... interested in aligning and amplifying support, adherence, and data collection vis ... with medical foundations mark the successful launch of this offer. ... GeneFo ...
Breaking Biology Technology:
(Date:4/24/2017)... , April 24, 2017 ... and partner with  Identity Strategy Partners, LLP (IdSP) ... "With or without President Trump,s March 6, 2017 ... Terrorist Entry , refugee vetting can be instilled with ... resettlement. (Right now, all refugee applications are suspended ...
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
(Date:4/11/2017)... April 11, 2017 No two people ... at the New York University Tandon School of ... have found that partial similarities between prints are ... in mobile phones and other electronic devices can ... The vulnerability lies in the fact that fingerprint-based ...
Breaking Biology News(10 mins):